Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy

E. Zucca; A. Conconi; G. Martinelli; R. Bouabdallah; A. Tucci; U. Vitolo; M. Martelli; R. Pettengell; G. Salles; C. Sebban; A. Lopez Guillermo; G. Pinotti; L. Devizzi; F. Morschhauser; H. Tilly; V. Torri; S. Hohaus; A.J. Ferreri; P. Zachée; A. Bosly; C. Haioun; C. Stelitano; M. Bellei; M. Ponzoni; A. Moreau; A. Jack; E. Campo; L. Mazzucchelli; F. Cavalli; P. Johnson; C. Thieblemont

doi:10.1200/JCO.2016.70.6994

Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy

E. Zucca, A. Conconi, G. Martinelli, R. Bouabdallah, A. Tucci, U. Vitolo, M. Martelli, R. Pettengell, G. Salles, C. Sebban, A. Lopez Guillermo, G. Pinotti, L. Devizzi, F. Morschhauser, H. Tilly, V. Torri, S. Hohaus, A.J. Ferreri, P. Zachée, A. BoslyC. Haioun, C. Stelitano, M. Bellei, M. Ponzoni, A. Moreau, A. Jack, E. Campo, L. Mazzucchelli, F. Cavalli, P. Johnson, C. Thieblemont

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1905-1912
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	35
Issue number	17
DOIs	https://doi.org/10.1200/JCO.2016.70.6994
Publication status	Published - 2017

Access to Document

10.1200/JCO.2016.70.6994

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020060003&doi=10.1200%2fJCO.2016.70.6994&partnerID=40&md5=8f60fc3b5b55f94c87e513aaa94a8680

Cite this

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Lopez Guillermo, A., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, A. J., Zachée, P., ... Thieblemont, C. (2017). Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy. Journal of Clinical Oncology, 35(17), 1905-1912. https://doi.org/10.1200/JCO.2016.70.6994

Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy. / Zucca, E.; Conconi, A.; Martinelli, G.; Bouabdallah, R.; Tucci, A.; Vitolo, U.; Martelli, M.; Pettengell, R.; Salles, G.; Sebban, C.; Lopez Guillermo, A.; Pinotti, G.; Devizzi, L.; Morschhauser, F.; Tilly, H.; Torri, V.; Hohaus, S.; Ferreri, A.J.; Zachée, P.; Bosly, A.; Haioun, C.; Stelitano, C.; Bellei, M.; Ponzoni, M.; Moreau, A.; Jack, A.; Campo, E.; Mazzucchelli, L.; Cavalli, F.; Johnson, P.; Thieblemont, C.

In: Journal of Clinical Oncology, Vol. 35, No. 17, 2017, p. 1905-1912.

Research output: Contribution to journal › Article › peer-review

Zucca, E, Conconi, A, Martinelli, G, Bouabdallah, R, Tucci, A, Vitolo, U, Martelli, M, Pettengell, R, Salles, G, Sebban, C, Lopez Guillermo, A, Pinotti, G, Devizzi, L, Morschhauser, F, Tilly, H, Torri, V, Hohaus, S, Ferreri, AJ, Zachée, P, Bosly, A, Haioun, C, Stelitano, C, Bellei, M, Ponzoni, M, Moreau, A, Jack, A, Campo, E, Mazzucchelli, L, Cavalli, F, Johnson, P & Thieblemont, C 2017, 'Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy', Journal of Clinical Oncology, vol. 35, no. 17, pp. 1905-1912. https://doi.org/10.1200/JCO.2016.70.6994

Zucca E, Conconi A, Martinelli G, Bouabdallah R, Tucci A, Vitolo U et al. Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy. Journal of Clinical Oncology. 2017;35(17):1905-1912. https://doi.org/10.1200/JCO.2016.70.6994

Zucca, E. ; Conconi, A. ; Martinelli, G. ; Bouabdallah, R. ; Tucci, A. ; Vitolo, U. ; Martelli, M. ; Pettengell, R. ; Salles, G. ; Sebban, C. ; Lopez Guillermo, A. ; Pinotti, G. ; Devizzi, L. ; Morschhauser, F. ; Tilly, H. ; Torri, V. ; Hohaus, S. ; Ferreri, A.J. ; Zachée, P. ; Bosly, A. ; Haioun, C. ; Stelitano, C. ; Bellei, M. ; Ponzoni, M. ; Moreau, A. ; Jack, A. ; Campo, E. ; Mazzucchelli, L. ; Cavalli, F. ; Johnson, P. ; Thieblemont, C. / Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy. In: Journal of Clinical Oncology. 2017 ; Vol. 35, No. 17. pp. 1905-1912.

@article{ac8cb4a97cf642638bbca88629410901,

title = "Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy",

author = "E. Zucca and A. Conconi and G. Martinelli and R. Bouabdallah and A. Tucci and U. Vitolo and M. Martelli and R. Pettengell and G. Salles and C. Sebban and {Lopez Guillermo}, A. and G. Pinotti and L. Devizzi and F. Morschhauser and H. Tilly and V. Torri and S. Hohaus and A.J. Ferreri and P. Zach{\'e}e and A. Bosly and C. Haioun and C. Stelitano and M. Bellei and M. Ponzoni and A. Moreau and A. Jack and E. Campo and L. Mazzucchelli and F. Cavalli and P. Johnson and C. Thieblemont",

note = "Cited By :8 Export Date: 7 March 2018",

year = "2017",

doi = "10.1200/JCO.2016.70.6994",

language = "English",

volume = "35",

pages = "1905--1912",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "17",

}

TY - JOUR

T1 - Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy

AU - Zucca, E.

AU - Conconi, A.

AU - Martinelli, G.

AU - Bouabdallah, R.

AU - Tucci, A.

AU - Vitolo, U.

AU - Martelli, M.

AU - Pettengell, R.

AU - Salles, G.

AU - Sebban, C.

AU - Lopez Guillermo, A.

AU - Pinotti, G.

AU - Devizzi, L.

AU - Morschhauser, F.

AU - Tilly, H.

AU - Torri, V.

AU - Hohaus, S.

AU - Ferreri, A.J.

AU - Zachée, P.

AU - Bosly, A.

AU - Haioun, C.

AU - Stelitano, C.

AU - Bellei, M.

AU - Ponzoni, M.

AU - Moreau, A.

AU - Jack, A.

AU - Campo, E.

AU - Mazzucchelli, L.

AU - Cavalli, F.

AU - Johnson, P.

AU - Thieblemont, C.

N1 - Cited By :8 Export Date: 7 March 2018

PY - 2017

Y1 - 2017

U2 - 10.1200/JCO.2016.70.6994

DO - 10.1200/JCO.2016.70.6994

M3 - Article

VL - 35

SP - 1905

EP - 1912

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 17

ER -